Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CEPI, University of Oxford and Serum Institute to establish investigational Nipah virus vaccine…
Up to 100,000 ChAdOx1 NipahB doses to support Phase II trial and potential emergency outbreak response
Merck & Co., Inc. and Eisai announce Phase 3 trial results for WELIREG plus LENVIMA in advanced…
LITESPARK-011 trial meets primary endpoint of progression-free survival in patients previously treated with anti-PD-1/L1 therapy
Akums Drugs & Pharmaceuticals begins construction of first overseas manufacturing facility in…
The Zambia-based facility will cover 40 acres, produce multiple dosage forms, and create more than 1,000 jobs as part of Akums’…
Thermo Fisher Scientific inaugurates expanded R&D Centre of Excellence in Bengaluru
The company invests over INR 160 crores to expand its Bengaluru facility, supporting antibody research, innovation, and local…
U.S. FDA approves Eli Lilly’s single-injection, once-monthly Omvoh regimen for adults with…
The approval allows a simplified once-monthly 200 mg maintenance dose of Omvoh (mirikizumab-mrkz) for adults with moderately to…
Sanofi India appoints Deepak Arora as Managing Director effective October 27, 2025
The appointment, approved by Sanofi India’s Board, will see Arora lead the company’s strategic priorities and operational…
MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan
The agreement grants MEDINET rights to develop and commercialise Stempeucel for CLTI indication in Japan, with manufacturing to…
USFDA classifies Hyderabad FDF Unit-I of Cohance Lifesciences as Official Action Indicated
Company initiates remediation measures; confirms limited revenue contribution from the facility and no material impact on…
Eli Lilly to acquire Adverum Biotechnologies and expand gene therapy portfolio with Ixo-vec
The acquisition will add Adverum’s intravitreal gene therapy programme for wet age-related macular degeneration to Lilly’s…
Panel Discussion: Quality and compliance: Powering global leadership in biopharma
Biopharma Leadership & Innovation Conclave 2025 | 8th October 2025 | Pune